Phocas Financial Corp. Vertex Pharmaceuticals Inc Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	BUY	$285.76 - $321.48 $114,304 - $128,592	400 New	400 $0
Q3 2019 Nov 15, 2019	SELL	$166.23 - $187.09 $66,492 - $74,836	-400 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$164.61 - $190.37 $65,844 - $76,148	400 New	400 $0
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $65,491 - $77,880	-400 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$151.91 - $192.21 $60,764 - $76,884	400 New	400 $66,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.